Nebraska Methodist Hospital chooses Elekta Synergy

TriMed Staff | | Health Imaging | Practice Management
Nebraska Methodist Hospital recently ordered an Elekta Synergy platform, one component of the facility's $13.5 million expansion of its oncology and neurosurgery programs.

The technology will enable doctors at the Omaha facility to obtain images of patients before their treatment, allowing them to visualize tumors at the point of treatment to more precisely target tumors with radiation beams.

Elekta Synergy is a linear accelerator-based system designed for image-guided radiation therapy (IGRT), which guides radiation delivery to a tumor, while sparing healthy tissues.

Elekta currently is taking orders for and installing Elekta Synergy linear accelerators at cancer clinics in the United States and Europe.

TriMed Staff

Related Content

Warning: Sidelined reactor could trigger medical isotope shortage
Malpractice watchers: Radiologists, imaging societies should bone up on the ‘science of visual perception’
ACR shares guidance for radiology providers facing IV supply shortages after hurricane
Incidental finding characteristics that warrant communication
AI implementation improves when radiology staff concerns are considered
Hospital organization sees impressive returns from POCUS integration

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.